Ceccarelli M, Assanta N, Chiaravalloti G, Rocopou C, Caiulo V A
Istituto di Clinica Pediatrica, Università degli Studi di Pisa.
Minerva Pediatr. 1992 May;44(5):237-40.
The aim of the study was to assess the utility of intravenous integral molecule immunoglobulin treatment in Guillain-Barré syndrome. The etiopathogenesis of this syndrome is still unclear but it seems increasingly likely that immune phenomena are involved in the genesis of the neurological lesions. This would explain the efficacy of iv immunoglobulin treatment even if the effective mechanism of action can still only be hypothesised.
该研究的目的是评估静脉注射整分子免疫球蛋白治疗格林-巴利综合征的效用。该综合征的病因发病机制仍不清楚，但神经病变的发生越来越有可能涉及免疫现象。这可以解释静脉注射免疫球蛋白治疗的疗效，即便其有效作用机制仍只能进行推测。
